Adaptive Biotechnologies Corp.
(NASDAQ: ADPT)
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
17.460
+0.330
(+1.93%)
Range
16.450 - 17.570
(6.81%)
Open
16.860
Previous Close
17.130
Bid Price
6.810
Bid Volume
30
Ask Price
6.830
Ask Volume
8
Volume
2,802,924
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
